社会的不利が認知症リスクにおける知識を上回る
Sandra Baez1,2, Sebastian Rodriguez Marquez1, Anna Marie Rosická3
1Departamento de Psicología, Universidad de Los Andes, Bogotá, Colombia.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|February 26, 2026
まとめ
低い社会経済的地位(SES)および教育レベルは、アルツハイマー病(AD)の知識よりも認知症リスクの強力な予測因子です。公衆衛生戦略は、認知症リスクを低減するために公平性に焦点を当てるべきです。
科学分野:
- 老年医学; 公衆衛生; 神経科学
背景:
- 公衆衛生イニシアチブは、リスク低減のために認知症の知識を高めることを目指しています。; 認知症の知識と、教育や社会経済的地位(SES)などの社会的決定要因の認知症リスクに対する比較影響は不明なままです。
研究 の 目的:
- 認知症の知識、教育、SESが行動および健康関連認知症リスクに及ぼす予測値を調査すること。; 様々な要因の認知症リスクに対する説明力と予測力を比較すること。
主な方法:
- 1730人の成人からの横断データの分析。; 線形回帰と機械学習を利用して認知症リスクの予測因子を評価しました。; 年齢、性別、教育、SES、認知症の家族歴、アルツハイマー病(AD)の知識などの要因を調査しました。
主要な成果:
- 低いSESと教育は、行動認知症リスクの増加の最も重要な予測因子でした。; SESは、健康関連認知症リスクに関連する唯一の要因でした。; アルツハイマー病(AD)の知識の正確さと自信は、どちらのリスク指標とも有意な関連を示しませんでした。; 機械学習モデルは、SESと教育を主要な予測特徴として特定しました。
結論:
- 社会経済的地位(SES)と教育は、アルツハイマー病(AD)の知識よりも認知症リスクと強く関連しています。; 効果的な認知症リスク低減戦略には、知識を高めるための公衆認識キャンペーンを超えた公平性に焦点を当てる必要があります。
関連する概念動画
Dementia
609
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
609
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Intellectual Disability
871
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
871
Stereotypes, Prejudice, and Discrimination
95.8K
Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
95.8K
Social Facilitation
36.7K
Not all intergroup interactions lead to negative outcomes. Sometimes, being in a group situation can improve performance. Social facilitation occurs when an individual performs better when an audience is watching than when the individual performs the behavior alone. This typically occurs when people are performing a task for which they are skilled.
36.7K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K


